ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer

作者：Rui Geng, Haojie Shang, Zhiqiang Chen, Kun Tang, Yijing Liu, Jintao Zhu · 发表于：Biomaterials · 年份：2025 · DOI：10.1016/j.biomaterials.2025.123677 · 被引用次数：11 · 研究领域：Immune cells in cancer、Bladder and Urothelial Cancer Treatments、Cancer Immunotherapy and Biomarkers